SABS
SAB Biotherapeutics Inc
3.10$
-3.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -2.12 | 3.70 | 0.73 | -5.39 | -4.55 | -3.70 | -0.73 | |
| 0.07 | 0.20 | 0.60 | 0.76 | 0.68 | 0.52 | 0.05 | |
| 0.09 | 0.48 | 0.85 | 0.61 | 0.44 | 0.32 | 0.08 | |
| 0.09 | 0.48 | 2.12 | -1.78 | – | – | – | |
| -0.21 | -4.43 | 4.27 | -0.05 | 0.42 | -0.25 | -0.06 | |
| 0.14 | 4.71 | 4.00 | 0.50 | 0.04 | 0.04 | 0.02 | |
| -0.14 | -4.71 | -4.00 | -0.48 | -0.03 | -1.29 | -1.98 | |
| – | – | 0.00 | -1.27 | 0.00 | – | – | |
| -0.14 | -0.34 | -0.08 | -0.24 | -0.07 | -0.10 | -0.01 | |
| 0.85 | 3.33 | 13.13 | 0.24 | 12.09 | -0.13 | 2.74 | |
| -1.41 | 2.32 | 9.85 | -5.63 | 7.52 | -5.15 | 0.03 | |
| -2.26 | -1.01 | -3.28 | -5.89 | -4.59 | -3.74 | -0.75 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.